semaglutide and hfpef improves heart failure-related symptoms physical function and results in greater weight loss compared with placebo in patients with # and #obesity ⬇️ #ESCCongress STEP-HFpEF trial STEP-HFpEF Trial

Este medicamento agonista del receptor GLP-1, aprobado por la FDA para diabetes y control de peso, genera cambios metablicos que van ms all del control glucmico

The Institutional Review Board of Shinshu University School of Medicine approved the study plans, and granted a waiver of informed consent, since diagnostic use of the samples was completed before this study and there was no risk to the patients

Fatigue is another common but manageable side effect

So, is semaglutide or bariatric surgery cheaper

Regular check-ins track your progress, manage your comfort, and adjust the dose as your body responds

Most side effects are mild, like nausea, tiredness, or diarrhoea, and improve as your body adjusts